Ro
Unicorn Β· $7BPlug and Play VenturesSilicon Valley, US Β· 32 known investors
Find your way into Ro
12,281 people in our graph share verified history with the Ro team β schools, employers, funds. One of them is your warm intro.
Ro is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.
Also known as Ro.co Β· Roman Β· Roman Health Ventures Inc.
Founders & leadership
Investors Β· 32
.jpeg){kind=logo}
.png)
Also in the syndicate Β· 5
Valuation Β· disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed β follow each entry's link for the claim.
Company profile
researched Aug 2026Ro, legally Roman Health Ventures Inc., is an American telehealth company headquartered in New York City. Patients complete an online visit describing their health, lifestyle, medical history and symptoms; an affiliated US-licensed provider reviews the responses and prescribes treatment when appropriate, with medication shipped to the patient's home. The company describes itself as vertically integrated, connecting nationwide telehealth, diagnostics and labs, in-home care and pharmacy distribution in a single end-to-end experience from diagnosis to delivery of medication to ongoing care, offered without requiring insurance.
Ro launched in October 2017 as Roman, focused on sexual health, and renamed itself Ro in September 2018 as it added conditions such as hair loss, cold sores and premature ejaculation. It later expanded into women's health, mental health, fertility, metabolic health, dermatology and skincare, covering more than 25 conditions, and operates Ro Pharmacy, which delivers more than 1,000 generic drugs including treatments for allergies, heart disease, anxiety, depression and diabetes. Weight management is a major line: Ro began treating obesity with Gelesis100 (Plenity) and in January 2023 expanded into GLP-1 receptor agonists through its Body Program, later adding Zepbound and Wegovy through integrations with Eli Lilly's LillyDirect and Novo Nordisk.
Through acquisitions of Workpath (in-home care and diagnostics software with an API) and Kit (at-home diagnostic tests, including finger-prick blood tests and weight measurement tools), Ro also runs a business-to-business operation powering in-home care and diagnostic services for health systems, clinical trial operators, labs, digital health companies and large corporates. The company distributes its consumer experience through the web and an iOS app that supports order tracking, treatment updates, a GLP-1 insurance coverage checker and content and support.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Founder mafia
3 people who came through Ro went on to found or lead other companies.
Competitors Β· 2
by search overlapCompanies competing with Ro for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 23
launches, deals, and filingsNovo Nordisk partnered with Ro, among other telehealth providers, to offer the first FDA-approved GLP-1 medication in pill form.
Ro announced that eligible patients can access Eli Lilly's Foundayo (orforglipron) and launched the FDA-approved Zepbound KwikPen with Eli Lilly.
Ro announced a diagnostic test developed with researchers to determine whether someone experiences food noise and its severity.
Ro announced partnerships with Charles Barkley and Serena Williams for its GLP-1 treatment program; the Williams campaign drew widespread controversy.
In response to GLP-1 supply shortages, Ro launched a crowdsourced supply tracker, later adding a free tool for checking insurance coverage of GLP-1 medications.
Ro expanded obesity treatment through GLP-1 receptor agonists via its Body Program; after FDA approval in 2023 it began prescribing Zepbound to medically eligible patients.
Ro agreed to create a registry of patients for future Alzheimer's disease research and clinical trials.
Ro acquired Kit, a startup offering at-home diagnostic tests including finger-prick blood tests and weight measurement tools.
Ro acquired women's reproductive health company Modern Fertility in a deal reported to be over $225 million.
$225M source β
Ro partnered with healthcare AI company Gauss to offer at-home COVID-19 rapid antigen tests pending FDA Emergency Use Authorization, and with Gelesis to distribute weight management treatment Plenity nationwide.
The former CEO of Ancestry.com joined Ro's board of directors.
Ro administered COVID-19 vaccinations in the homes of eligible New Yorkers, initially in select Yonkers zip codes, targeting elderly and homebound populations.
Ro acquired Workpath, a software platform enabling on-demand in-home care and diagnostic services via API, including sending phlebotomists to patient homes for blood draws.
Ro launched free COVID-19 telehealth assessments and partnered with Uber to provide free assessments to Uber drivers.
The company renamed itself Ro and expanded treatments to hair loss, cold sores and premature ejaculation.
Reddit co-founder Alexis Ohanian added as a board director alongside the Series A round.
The company launched as Roman, offering telehealth treatment for sexual health conditions alongside a pharmacy to distribute medications.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Ro: Online Healthcare - App Store - Appleapps.apple.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Ro do?
- Ro is a US direct-to-patient telehealth company combining online care, diagnostics, labs and pharmacy delivery.
- Who founded Ro?
- Ro was founded by Zachariah Reitano, Rob Schutz, Saman Rahmanian.
- Who are Ro's investors?
- Ro's investors include Ambush Capital, Ansa Capital, Black Jays Ventures, blue 9 capital, BoxGroup, BY Venture Partners, Cade Ventures, Chapter One and 19 more.
- Where is Ro headquartered?
- Ro is headquartered in Silicon Valley, US.